Rupture of a cerebral aneurysm following carotid endarterectomy
Following carotid revascularization with either carotid endarterectomy or stenting, the impaired cerebral autoregulation can lead to cerebral hyperperfusion syndrome. This impaired autoregulation and increased flow may also put patients with unruptured aneurysms at risk for subarachnoid hemorrhage in the perioperative period. A patient is reported who underwent carotid endarterectomy for symptomatic carotid stenosis. A small anterior communicating artery aneurysm was identified preoperatively, which ruptured 2 days after carotid endarterectomy. Screening for cerebral aneurysms prior to carotid revascularization will allow operators to minimize this risk, either through prior treatment of the aneurysm or tight blood pressure control in the perioperative period. We do occasionally see intracranial aneurysms associated with carotid artery stenosis. And, we leave then alone....while reopening the stenosis. However, this case shows that this approach is not without vice...Rupture of a cerebral aneurysm following carotid endarterectomy
Pipeline embolization device (PED) for neurovascular reconstruction: initial experience in the treatment of 101 intracranial aneurysms and dissections
This study to date is the largest registry of the flow diversion devices: PIPELINE or SILK.
The authors, here too, like all other smaller studies, have said that the complication rates are acceptable.
This study had 6 major complications in the 90 aneurysms followed up, only 52% had complete occlusion, 66% needed multiple stents which are exorbitantly costly...wonder what the definition of 'acceptable complication rate' is...which most of these studies say...no doubt industry sponsored.
But where ever feasible why not do a parent vessel sacrifice, which is much more safe, durable and cheap...or...use stent grafts/enterprise stent which are much cheaper than the flow diverters..
Pipeline embolization device (PED) for neurovascular reconstruction: initial experience in the treatment of 101 intracranial aneurysms and dissections:
PED between September 2009 and January 2011. The targeted vessels include 79 (78%) in the anterior circulation and 22 (22%)
in the posterior circulation. We treated 96 aneurysms and 5 vessel dissections. Multiple devices were implanted in 67 lesions
(66%).
follow-up examinations were carried out in 80 patients (91%) with 90 lesions and revealed complete cure of the target lesion(s)
in 47 (52%), morphological improvement in 32 lesions (36%), and no improvement in 11 lesions (12%). Six major complications
were encountered: one fatal aneurysm rupture, one acute and one delayed PED thrombosis, and three hemorrhages in the dependent
brain parenchyma.
aneurysms, fusiform aneurysms, remnants of aneurysms, aneurysms with a high likelihood of failure with conventional endovascular
techniques, and dissected vessels. While vessel reconstruction, performed after dissection, is achieved within days, remodeling
of aneurysmal dilatations may take several months. Dual platelet inhibition is obligatory. Parenchymal bleeding into brain
areas dependent on the target vessel is uncommon.
- Authors
- Sebastian Fischer, Neuroradiologische Klinik, Neurozentrum, Klinikum Stuttgart, Stuttgart, Germany
- Zsolt Vajda, Neuroradiologische Klinik, Neurozentrum, Klinikum Stuttgart, Stuttgart, Germany
- Marta Aguilar Perez, Neuroradiologische Klinik, Neurozentrum, Klinikum Stuttgart, Stuttgart, Germany
- Elisabeth Schmid, Neurologische Klinik, Neurozentrum, Klinikum Stuttgart, Stuttgart, Germany
- Nikolai Hopf, Neurochirurgische Klinik, Neurozentrum, Klinikum Stuttgart, Stuttgart, Germany
- Hansjörg Bäzner, Neurologische Klinik, Neurozentrum, Klinikum Stuttgart, Stuttgart, Germany
- Hans Henkes, Neuroradiologische Klinik, Neurozentrum, Klinikum Stuttgart, Stuttgart, Germany
- Journal Neuroradiology
- Online ISSN 1432-1920
- Print ISSN 0028-3940
Treatment of intracranial aneurysms. Reconstruction of the parent artery with flow-diverting (Silk) stent
Treatment of intracranial aneurysms. Reconstruction of the parent artery with flow-diverting (Silk) stent:
to treat with usual endovascular or surgical methods. It is still uncertain which aneurysms are suitable for this new treatment.
We present the periprocedural complications, immediate result, late complications, imaging follow-up at 6 and 12 months and
clinical follow-up at 2–23 months.
and morbidity rates were 1 of 22 (5%) and 1 of 22 (5%), respectively. Clinical outcome was unchanged in 16 patients (72%),
3 patients improved (14%) and 3 patients worsened (14%). The end-of-procedure angiography did not show complete occlusion
of any of the aneurysms, but at 6 months follow-up angiography, 17 of 25 aneurysms (68%) were completely occluded, and at
12 months, 18 of 21 aneurysms (86%) were occluded.
but continues during the following time. Most delayed complications occur immediately after discontinuing the anticoagulation
medication. Considering the complexity of the aneurysms treated, the rate of complications is acceptable.
- Content Type Journal Article
- Category Interventional Neuroradiology
- Pages 1-10
- DOI 10.1007/s00234-011-0949-9
- Authors
- Aase Wagner, Department of Neuroradiology, University Hospital Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
- Marie Cortsen, Department of Neuroradiology, University Hospital Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
- John Hauerberg, Department of Neurosurgery, University Hospital Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
- Bertil Romner, Department of Neurosurgery, University Hospital Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
- Mathias Pedersen Wagner, Department of Neuroradiology, University Hospital Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
- Journal Neuroradiology
- Online ISSN 1432-1920
- Print ISSN 0028-3940
This is a small patient group who underwent flow diversion with the SILK stent. 1/22 died and 1/22 had clinical deficits. 18/22 aneurysms occluded at 1 year. I do not think these results are really very good
The value of magnetic resonance imaging for the detection of the bleeding source in non-traumatic intracerebral haemorrhages: a comparison with conventional digital subtraction angiography
Three cheers for non invasive imaging...
The value of magnetic resonance imaging for the detection of the bleeding source in non-traumatic intracerebral haemorrhages: a comparison with conventional digital subtraction angiography:
pathologies in patients with intracerebral haemorrhages (ICH). However, the use of magnetic resonance imaging (MRI) in the
diagnostic workup of ICHs has considerably increased in recent years. Our aim was to evaluate the diagnostic accuracy and
yield of MRI for the detection of the underlying aetiology in ICH patients.
during their diagnostic workup) were included in the study. Magnetic resonance images were retrospectively analysed by two
independent neuroradiologists to determine the localisation and cause of the ICH. DSA was used as a reference standard.
one dural arteriovenous fistula and one vasculitis). All of these cases were correctly diagnosed by both readers on MRI. In
addition, MRI revealed the following probable bleeding causes in 39 of the 60 DSA-negative patients: cerebral amyloid angiopathy
(17), cavernoma (9), arterial hypertension (8), haemorrhagic transformation of an ischaemic infarction (3) and malignant brain
tumour with secondary ICH (2).
In addition, MRI provided valuable information regarding DSA-negative ICH causes, and thus had a high diagnostic yield in
ICH patients.
- Content Type Journal Article
- Category Diagnostic Neuroradiology
- Pages 1-8
- DOI 10.1007/s00234-011-0953-0
- Authors
- Nina Lummel, Department of Neuroradiology, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany
- Jürgen Lutz, Department of Neuroradiology, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany
- Hartmut Brückmann, Department of Neuroradiology, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany
- Jennifer Linn, Department of Neuroradiology, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany
- Journal Neuroradiology
- Online ISSN 1432-1920
- Print ISSN 0028-3940
Applicability of Tableside Flat Panel Detector CT Parenchymal Cerebral Blood Volume Measurement in Neurovascular Interventions: Preliminary Clinical Experience [INTERVENTIONAL]
- P. Mordasini,M. El-Koussy,C. Brekenfeld,G. Schroth,U. Fischer,J. Beck,and J. Gralla. Applicability of Tableside Flat Panel Detector CT Parenchymal Cerebral Blood Volume Measurement in Neurovascular Interventions: Preliminary Clinical Experience AJNR Am J Neuroradiol 2011 originally published online on September 29, 2011, 10.3174/ajnr.A2715.
Applicability of Tableside Flat Panel Detector CT Parenchymal Cerebral Blood Volume Measurement in Neurovascular Interventions: Preliminary Clinical Experience [INTERVENTIONAL]:
BACKGROUND AND PURPOSE:
CBV is a vital perfusion parameter in estimating the viability of brain parenchyma (eg, in cases of ischemic stroke or after interventional vessel occlusion). Recent technologic advances allow parenchymal CBV imaging tableside in the angiography suite just before, during, or after an interventional procedure. The aim of this work was to analyze our preliminary clinical experience with this new imaging tool in different neurovascular interventions.
MATERIALS AND METHODS:FPD-CBV measurement was performed on a biplane FPD angiographic system. Eighteen patients (11 women, 7 men) were examined (age range, 18–86 years; median, 58.7 years). In the 10 patients with stroke, the extent of intracranial hypoperfusion was evaluated. The remaining 8 patients had an intracranial hemorrhage; periprocedural CBV was evaluated during the course of interventional treatment.
RESULTS:In the 18 cases studied, 23 CBV measurements were performed. Twenty acquisitions were of sufficient diagnostic quality. The remaining 3 acquisitions failed technically, 1 due to motion artifacts and 2 due to injection technique and/or hardware failure.
CONCLUSIONS:FPD-CBV measurement in the angiography suite provides a feasible and helpful tool for peri-interventional neuroimaging. It extends the intraprocedural imaging modalities to the level of tissue perfusion. However, the technique has technical limitations and shows room for improvement in the future.
Border Zone Infarcts: Pathophysiologic and Imaging Characteristics
Neurologic/Head and Neck Imaging:
- Rajiv Mangla,
- Balasubramanya Kolar,
- Jeevak Almast,
- and Sven E. Ekholm
The causal mechanisms and anatomic locations of external (cortical) and internal (subcortical) border zone infarcts are reviewed, and their appearances at MR imaging, CT, and transcranial Doppler US are described in detail.
Border Zone Infarcts: Pathophysiologic and Imaging Characteristics [Neurologic/Head and Neck Imaging]:
Border zone or watershed infarcts are ischemic lesions that occur in characteristic locations at the junction between two main arterial territories. These lesions constitute approximately 10% of all brain infarcts and are well described in the literature. Their pathophysiology has not yet been fully elucidated, but a commonly accepted hypothesis holds that decreased perfusion in the distal regions of the vascular territories leaves them vulnerable to infarction. Two types of border zone infarcts are recognized: external (cortical) and internal (subcortical). To select the most appropriate methods for managing these infarcts, it is important to understand the underlying causal mechanisms. Internal border zone infarcts are caused mainly by hemodynamic compromise, whereas external border zone infarcts are believed to result from embolism but not always with associated hypoperfusion. Various imaging modalities have been used to determine the presence and extent of hemodynamic compromise or misery perfusion in association with border zone infarcts, and some findings (eg, multiple small internal infarcts) have proved to be independent predictors of subsequent ischemic stroke. A combination of several advanced techniques (eg, diffusion and perfusion magnetic resonance imaging and computed tomography, positron emission tomography, transcranial Doppler ultrasonography) can be useful for identifying the pathophysiologic process, making an early clinical diagnosis, guiding management, and predicting the outcome.
Flow Diversion in Aneurysms Trial: the Design of the FIAT study
With the increasing interest among interventional neuroradiologists of flow diversion therapy of intracranial aneurysms, it was only matter of time before an RCT came along. So here it is... The FIAT trial, consisting of both RCT and registry arms, to be conducted with a wel respected group led by Jean Raymond, and which will compare the imaging and clinical results of flow diversion with stents vs other techniques (observation, coiling, parent vessel sacrifice, surgery etc.)...
Flow Diversion in Aneurysms Trial: the Design of the FIAT study
Centre Hospitalier de l'Université de Montréal (CHUM), Notre-Dame Hospital, Department of Radiology and Interventional Neuroradiology Research Unit; Montreal, Quebec, Canada
Key words: aneurysms, intracranial stents, clinical trial
Summary
Intracranial aneurysms, particularly large and giant, fusiform or recurrent aneurysms are increasingly treated with flow diverters (FDs), a recently introduced and approved neurovascular device. While some rare cases may not be treated any other way, in most patients a more conventional, conservative, or validated approach such as coiling, parent vessel occlusion, or surgical clipping exists. Only a randomized clinical trial can answer the question of which treatment option leads to better patient outcomes.We report the design of the FIAT study, a clinical care trial aiming to compare angiographic and clinical outcomes following treatment with a Flow-Diverter or with the best conventional treatment option.
The FIAT study will include both a randomized and a registry portion. Patients will be proposed randomization to either FD stenting or best conventional treatment option (observation, coiling, stenting, or clipping) as determined by the treating physician. FIAT will recruit a total of 338 patients, to show that i) FD stenting can be performed with an ‘acceptable' immediate complication rate of less than 15% morbidity and mortality (defined as mRS > 2); ii) FD stenting can increase from 75 to 90% the proportion of patients with a “good outcome”, defined as complete or near-complete occlusion of the aneurysm AND a good clinical outcome (mRS ≤ 2) at one year, as compared to the best conventional option.
The FIAT study provides a scientific and ethical context to care for patients eligible for flow-diversion therapy.

